2,2-Dimethyl-N-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-2-yl)propanamide

Catalog No. :
ACIMWY012
CAS No. :
338416-64-1
Molecular Formula :
C13H19N3O2
Molecular Weight :
249.31

IUPAC Name:N-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-2-yl)pivalamide

2,2-Dimethyl-N-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-2-yl)propanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$281.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2-Dimethyl-N-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-2-yl)propanamide
IUPAC NameN-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-2-yl)pivalamide
MDL No.MFCD01315826
Molecular FormulaC13H19N3O2
Molecular Weight249.31
SMILESCC(C)(C)C(NC(N1)=NC2=C(CCCC2)C1=O)=O
InChI KeyOMVCIXNVVCWNPY-UHFFFAOYSA-N
Synonym2,2-DIMETHYL-N-(4-OXO-3,4,5,6,7,8-HEXAHYDRO-2-QUINAZOLINYL)PROPANAMIDE;2,2-dimethyl-N-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-2-yl)propanamide;Propanamide, N-(3,4,5,6,7,8-hexahydro-4-oxo-2-quinazolinyl)-2,2-dimethyl-
CAS No.338416-64-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIMWY012 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIMWY012 route product structure diagram
    ACIMWY012338416-64-1
Inquiry

2. ACIMWY012 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIMWY012 route product structure diagram
    ACIMWY012338416-64-1
Inquiry

Comments (0)